ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 185 filers reported holding ARIAD PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 1.24 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $190,000 | -9.1% | 15,280 | 0.0% | 0.01% | -9.1% |
| Q3 2016 | $209,000 | +104.9% | 15,280 | +10.8% | 0.01% | +57.1% |
| Q2 2016 | $102,000 | +22.9% | 13,787 | +6.7% | 0.01% | +16.7% |
| Q1 2016 | $83,000 | +2.5% | 12,921 | 0.0% | 0.01% | +20.0% |
| Q4 2015 | $81,000 | +8.0% | 12,921 | 0.0% | 0.01% | 0.0% |
| Q3 2015 | $75,000 | -29.9% | 12,921 | 0.0% | 0.01% | -28.6% |
| Q2 2015 | $107,000 | -12.3% | 12,921 | -12.5% | 0.01% | -12.5% |
| Q1 2015 | $122,000 | +20.8% | 14,771 | 0.0% | 0.01% | +14.3% |
| Q4 2014 | $101,000 | +26.2% | 14,771 | 0.0% | 0.01% | +16.7% |
| Q3 2014 | $80,000 | -14.9% | 14,771 | 0.0% | 0.01% | -14.3% |
| Q2 2014 | $94,000 | – | 14,771 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 12,850,000 | $175,916,000 | 40.51% |
| Consonance Capital Management LP | 8,695,742 | $119,045,000 | 11.46% |
| Tamarack Advisers, LP | 3,700,000 | $49,358,000 | 7.76% |
| Opaleye Management Inc. | 1,045,000 | $14,306,000 | 7.49% |
| Granite Point Capital Management, L.P. | 457,415 | $6,262,000 | 2.44% |
| Redmile Group, LLC | 2,138,471 | $29,276,000 | 2.33% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 206,010 | $2,820,000 | 2.17% |
| Palo Alto Investors LP | 2,587,617 | $35,424,000 | 2.06% |
| PRICE MICHAEL F | 940,000 | $12,869,000 | 1.71% |
| HighVista Strategies LLC | 638,086 | $8,735,000 | 1.62% |